377220 — From Bio Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩52bn
- KR₩65bn
- KR₩67bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 61,879 | 108,045 | 135,103 | 99,330 | 66,724 |
Cost of Revenue | |||||
Gross Profit | 48,142 | 85,019 | 102,104 | 69,309 | 45,955 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 56,827 | 88,102 | 123,762 | 98,533 | 82,239 |
Operating Profit | 5,052 | 19,943 | 11,341 | 797 | -15,515 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -20,879 | -4,014 | 11,638 | 1,512 | -15,740 |
Provision for Income Taxes | |||||
Net Income After Taxes | -21,025 | -7,813 | 11,282 | 1,318 | -11,609 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -21,025 | -7,813 | 11,282 | 3,241 | -11,076 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -21,025 | -7,813 | 11,282 | 3,241 | -11,076 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -753 | -257 | 464 | 118 | -389 |
Dividends per Share |